Screener
Privia Health Group, Inc. PRVA Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 1.9%+0.9pp | 1.6%+0.4pp | 1.6%+0.6pp | 1.4%+0.6pp | 1%+0.3pp | |
| Net margin | 1.2%+0.4pp | 1%+0.1pp | 1.1%+0.3pp | 0.9%+0.1pp | 0.8%-0.1pp | |
| Returns | ||||||
| Return on equity | 3.8%+1.5pp | 3.1%+0.6pp | 3.3%+0.9pp | 2.7%+0.5pp | 2.3%-0.3pp | |
| Return on invested capital | 8%+3.2pp | 8.2%+2.0pp | 11.1%+4.8pp | 7.6%+4.0pp | 4.8%+0.9pp | |
| Efficiency | ||||||
| Asset turnover | 1.7×+0.1× | 1.7×+0.1× | 1.7×+0.1× | 1.6×0.0× | 1.6×-0.1× | |
| Liquidity | ||||||
| Current ratio | 1.6×0.0× | 1.6×-0.3× | 1.6×-0.3× | 1.7×-0.1× | 1.7×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -7.1×+6.7× | -8.6×+7.5× | -10.7×+9.4× | -11.7×+8.8× | -13.8×+5.2× | |
| Per Share | ||||||
| Book value per share | $5.93+11.6% | $5.75+11.5% | $5.72+13.1% | $5.51+12.6% | $5.32+11.9% | |
| Valuation | ||||||
| Market capitalization | $2.77B+15.0% | $2.54B-6.0% | $2.92B+24.3% | $3.06B+40.7% | $2.68B+30.3% | |
| Price / earnings | 98.6×-63.9× | 116.9×-56.3× | 127.2×-35.8× | 168.2×-1.2× | 180.8×+42.9× | |
| Price / sales | 1.2×-0.1× | 1.1×-0.4× | 1.4×0.0× | 1.5×+0.2× | 1.4×+0.2× | |
| Price / book | 3.5×0.0× | 3.4×-0.7× | 4×+0.3× | 4.3×+0.8× | 3.9×+0.5× | |
| EV / EBITDA | 41.6×-31.5× | 44.7×-33.3× | 55.4×-21.3× | 70.3×-16.0× | 82.9×-0.9× |
FAQ
- Where do Privia Health Group, Inc.'s ratios come from?
- Every ratio is computed from Privia Health Group, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
